INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 273 filers reported holding INTRA CELLULAR THERAPIES INC in Q1 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $230,342 | -81.5% | 4,422 | -77.5% | 0.00% | -77.8% |
Q2 2023 | $1,242,465 | +515445.6% | 19,622 | +341.7% | 0.01% | +350.0% |
Q1 2023 | $241 | +2.1% | 4,442 | -0.4% | 0.00% | 0.0% |
Q4 2022 | $236 | -99.9% | 4,462 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $205,000 | -12.4% | 4,462 | +9.1% | 0.00% | 0.0% |
Q2 2022 | $234,000 | -17.0% | 4,091 | -11.3% | 0.00% | 0.0% |
Q1 2022 | $282,000 | -33.0% | 4,611 | -48.0% | 0.00% | -33.3% |
Q4 2021 | $421,000 | +28.0% | 8,869 | +0.5% | 0.00% | +50.0% |
Q3 2021 | $329,000 | -7.3% | 8,822 | +1.4% | 0.00% | 0.0% |
Q2 2021 | $355,000 | +20.3% | 8,700 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $295,000 | +6.5% | 8,700 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $277,000 | +44.3% | 8,700 | +16.4% | 0.00% | 0.0% |
Q3 2020 | $192,000 | -27.5% | 7,475 | -27.6% | 0.00% | 0.0% |
Q2 2020 | $265,000 | +75.5% | 10,322 | +4.8% | 0.00% | 0.0% |
Q1 2020 | $151,000 | -53.1% | 9,850 | +5.0% | 0.00% | -33.3% |
Q4 2019 | $322,000 | +360.0% | 9,380 | 0.0% | 0.00% | +200.0% |
Q3 2019 | $70,000 | +775.0% | 9,380 | +1776.0% | 0.00% | – |
Q3 2016 | $8,000 | -57.9% | 500 | 0.0% | 0.00% | – |
Q2 2016 | $19,000 | +35.7% | 500 | 0.0% | 0.00% | – |
Q1 2016 | $14,000 | – | 500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DCF Advisers, LLC | 359,000 | $18,790,000 | 7.62% |
Velan Capital Investment Management LP | 150,000 | $7,851,000 | 6.09% |
SILVERARC CAPITAL MANAGEMENT, LLC | 195,000 | $10,206,000 | 4.14% |
Vantage Consulting Group Inc | 226,670 | $11,864,000 | 3.19% |
Vahanian & Associates Financial Planning Inc. | 71,742 | $3,755,000 | 3.03% |
Nicholas Investment Partners, LP | 652,886 | $34,172,000 | 2.16% |
COOPER/HAIMS ADVISORS, LLC | 61,116 | $3,199,000 | 1.97% |
Bellevue Group AG | 3,628,919 | $189,938,000 | 1.96% |
WASATCH ADVISORS LP | 8,235,171 | $431,029,000 | 1.76% |
Quantum Private Wealth, LLC | 77,622 | $4,062,000 | 1.54% |